Monopar Therapeutics Inc.
MNPR | NASDAQ
$95.12
-$0.60 (-0.63%)
Sep 22, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.31B | -3.89M | -5.2M | -3.44M | -2.45M | -2.62M | -10.93M | -1.3M | -1.72M | -1.64M | -1.81M | -1.95M | -2.2M | -2.43M | -2.9M | -2.4M | -2.76M | -2.46M | -2.68M | -2.46M | -2.08M | -1.88M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.43B | 1.69M | 1.1M | 1.1M | 1.28M | 1.36M | 278.61K | 199.12K | 334.39K | 328.66K | 474.21K | 474.14K | 473.3K | 476.21K | 393.42K | 390.74K | 357.29K | 499.81K | 350.16K | 392.07K | 357.59K | 368.23K |
Other Working Capital | -1.77B | -187.06K | 704.4K | -107.24K | -88.3K | -3.5M | 2.96M | 2.96K | 49.87K | -31.62K | 6.81K | 36.67K | -3.05K | -60.84K | 5.25K | 137.95K | 46.05K | 21.73K | -42.09K | -11.24K | 19K | -51.88K |
Other Non-Cash Items | 851.23M | -799.63K | -716.46K | n/a | 119.51K | -119.51K | 4.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -532.32K | 340.61K | 136.3K | 297.45K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -213.82M | -474.2K | 1.44M | 247.86K | -22.9K | -4.27M | 4.1M | 31.65K | -295.88K | -342.86K | -206.19K | -460.22K | -374.77K | -312.77K | 1.2M | -139.57K | 1.14M | 21.73K | -42.09K | -11.24K | 19K | -422.27K |
Operating Cash Flow | -3.25B | -3.47M | -3.37M | -2.09M | -1.08M | -5.66M | -2M | -1.07M | -1.68M | -1.66M | -1.55M | -1.94M | -2.1M | -2.27M | -1.3M | -2.15M | -1.27M | -2.47M | -2.03M | -1.94M | -1.41M | -1.94M |
Capital Expenditures | n/a | -4 | n/a | n/a | 1 | -4 | n/a | n/a | -2 | n/a | -1 | n/a | -2 | n/a | -4 | -2 | 3 | n/a | 6 | -4 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -47.58B | -40.84M | -78.29M | -5.73M | -1.21M | -1.93M | -14.34M | n/a | -2.42K | -983.31K | 9.24K | -2.97M | -1.96M | -2.96M | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 51.7B | 35.25M | 16.1M | 3.6M | 2.4M | 1.6M | n/a | 985.73K | n/a | n/a | 2.96M | 2.96M | 4.92M | 1.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 4.12B | -5.58M | -62.19M | -2.13M | 1.19M | -325.83K | -14.34M | 985.73K | -2.42K | -983.31K | 2.97M | -13.05K | 2.95M | -983.44K | -4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -200.2K | n/a | -35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.67K | -7.77K | -9.98K | -24K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -654.96M | n/a | -298.09K | -381.56K | -321.56K | -131.13K | -66.95K | -16.53K | -9.92K | -10.74K | -5.32K | -8.21K | -16.61K | -16.83K | -19.64K | 25.17K | -65.5K | n/a | n/a | n/a | n/a | -4.02K |
Financial Cash Flow | -647.39M | -200.2K | -384.68K | 92.39M | -316.85K | -115.68K | 56.14M | -16.53K | -9.92K | 3.18M | 334.55K | 246.7K | 641.18K | 804.8K | 138.74K | -23.74K | -65.46K | -16.67K | -7.77K | -9.98K | -24K | 10.92M |
Net Cash Flow | 213.5M | -9.29M | -65.84M | 88.18M | -209.47K | -6.1M | 39.8M | -99.85K | -1.69M | 541.5K | 1.75M | -1.7M | 1.49M | -2.46M | -6.13M | -2.15M | -1.36M | -2.48M | -2.04M | -1.95M | -1.43M | 8.99M |
Free Cash Flow | -3.25B | -3.47M | -3.37M | -2.09M | -1.08M | -5.66M | -2M | -1.07M | -1.68M | -1.66M | -1.55M | -1.94M | -2.1M | -2.27M | -1.3M | -2.15M | -1.27M | -2.47M | -2.03M | -1.94M | -1.41M | -1.94M |
Adj. Free Cash Flow | -4.68B | -5.17M | -4.47M | -3.19M | -2.36M | -7.02M | -2.28M | -1.27M | -2.01M | -1.98M | -2.02M | -2.41M | -2.57M | -2.75M | -1.7M | -2.54M | -1.62M | -2.97M | -2.38M | -2.33M | -1.76M | -2.31M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | -4 | n/a | n/a | 1 | -4 | n/a | n/a | -2 | n/a | -1 | n/a | -2 | n/a | -4 | -2 | 3 | n/a | 6 | -4 | n/a | n/a |
Owner Earnings | -3.25B | -3.47M | -3.37M | -2.09M | -1.08M | -5.66M | -2M | -1.07M | -1.68M | -1.66M | -1.55M | -1.94M | -2.1M | -2.27M | -1.3M | -2.15M | -1.27M | -2.47M | -2.03M | -1.94M | -1.41M | -1.94M |
Add to Watchlist
Select watchlists to add or remove MNPR